Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: Results of the BP-CARE study

European Heart Journal

Volumn 32, Issue 2, 2011, Pages 218-225

  Grassi, Guido ^a   Cifkova, Renata ^b   Laurent, Stephane ^c   Narkiewicz, Krzysztof ^d   Redon, Joseph ^e   Farsang, Csaba ^f   Viigimaa, Margus ^g   Erdine, Serap ^h   Brambilla, Gianmaria ⁱ   Bombelli, Michele ^a   Delloro, Raffaella ^a   Notari, Massimo ^j   Mancia, Giuseppe ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e UNIVERSITY OF VALENCIA   (Spain)

^f Szent Imre Hospital   (Hungary)

^g TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ IRCCS MULTIMEDICA   (Italy)

^j Menarini International   (Italy)

more..

Author keywords

Blood pressure; Cardiovascular risk; Hypertension; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MONOTHERAPY; OPHTHALMOSCOPY; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN;

AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY, AMBULATORY; EUROPE; EUROPE, EASTERN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 78651496814     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq394     Document Type: Article

References (43)

1. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med 1996;156:1994-2001.
2. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 1997;30:1267-1273.
3. Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J 1988;296:1702-1706.
4. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 1998;351:934-939.
5. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000;284:311-318.
6. Smith NL, Savage PJ, Heckbert SR, Barzilay JI, Bittner VA, Kuller LH, Psaty BM. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc 2002;50: 416-423.
7. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, Valentini M, Tessari F, Ambrosioni E. SMOOTH investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006;24:837-843.
8. Mancia G, Facchetti R, Bombelli M, Friz HP, Grassi G, Giannattasio C, Sega R. Relationship of office, home and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005;45:1072-1077.
9. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007;49:40-47.
10. Cohen HW, Hailpern SM, Alderman MH. Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients. Hypertension 2004; 43:983-987.
11. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002;20:1461-1464.
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187. (Pubitemid 46924065)
13. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375-2414.
14. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997;18:1569-1582.
15. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-572.
16. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-137.
17. Mancia G, Pessina AC, Trimarco B, Grassi G; SILVIA (Studio Italiano Longitudinale sulla Valutazione della Ipertensione Arteriosa nel 2000) Study Group. Blood pressure control according to new guidelines targets in low-to high-risk hypertensives managed in specialist practice. J Hypertens 2004;22:2387-2396.
18. Mancia G, Volpe R, Boos S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004;22:51-57.
19. Vitezic D, Burke T, Mrsic-Pelcic J, Mavric Z, Zaputovic L, Zupan G, Simonic A. Characteristics of blood-pressure control in treated hypertensive patients in Croatia. Blood Press 2005;2 (Suppl. 1):S33-S41.
20. Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, Pikhart H, Nicholson A, Marmot M. Determinants of cardiovascular disease and other noncommunicable diseases in Central and Eastern Europe: rationale and design of HAPIEE study. BMC Public Health 2006;6:255-257.
21. Pilav A, Nissinen A, Haukkala A, Niksic D, Laatikainen T. Cardiovascular risk factors in the Federation of Bosnia and Herzegovina. Eur J Public Health 2007; 17:75-79.
22. Ćfková R. Arterial hypertension as a public health issue in the Czech Republic. Blood Press, 2005, 2 (Suppl. 1), S25-S28.
23. Dzerve V, Lejnieks A. Hypertension in Latvia - epidemiology and management. Blood Press 2005;14 (Suppl. 2):S29-S32.
24. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846-853.
25. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
26. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004;44:84-93.
27. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, Aznar J, González-Esteban J. Differences in blood pressure control and stroke mortality across Spain: the Prevención De Riesgo De Ictus (PREV-ICTUS) study. Hypertension 2007;49:799-805.
28. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005;23: 1575-1581.
29. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK. Stroke and coronary heart disease in treated hypertension-a prospective cohort study over three decades. J Intern Med 2005;257:496-502.
30. Ezzati M, Oza S, Danaei G, Murray CJ. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation 2008;117:905-914.
31. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000;85:251-255.
32. Mancia G, Seravalle G, Grassi G. Systolic blood pressure: an underestimated cardiovascular risk factor. J Hypertens 2002;20:S21-S27.
33. Franklin SS. Systolic blood pressure: it's time to take control. Am J Hypertens 2004; 17:49S-54S.
34. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention?. J Hypertens 2003;21: 1199-1205.
35. Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the global cardiometabolic risk profile in patients with hypertension disease survey. J Hypertens 2008;26:2064-2070.
36. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, Sega R. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med 2002;162:582-586. (Pubitemid 34193546)
37. Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009;27:923-934.
38. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood pressure measurements by the doctor on patient's blood pressure and heart rate. Lancet 1983;II:695-698. (Pubitemid 13002515)
39. Wilson MD, Barron JJ, Johnson KA, Powell RW, Sood VC, Cziraky MJ, Kalmanowicz J, Partsch DJ, Patwell JT. Determination of ambulatory blood pressure control in treated patients with controlled office blood pressures. Blood Press Monit 2000;5:263-269.
40. Banegas JR, Segura J, Sobrino J, Rodŕguez-Artalejo F, De la Sierra A, De la Cruz JJ, Gorostidi M, Sarŕa A, Ruilope LM. Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Effectiveness of blood pressure control outside the medical setting. Hypertension 2007;49:62-68.
41. Gorostidi M, Sobrino J, Segura J, Sierra C, De la Sierra A, Hernández del Rey R, Vinyoles E, Galcerán JM, López-Eady MD, Maŕn R, Banegas JR, Sarŕa A, Coca A, Ruilope LM. Spanish Society of Hypertension ABPM Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007;25:977-984.
42. Banegas JR, Segura J, De la Sierra A, Gorostidi M, Rodŕguez- Artalejo F, Sobrino J, De la Cruz JJ, Vinyoles E, del Rey RH, Graciani A, Ruilope LM. Spanish Society of Hypertension ABPM Registry Investigators. Gender differences in office and ambulatory control of hypertension. Am J Med 2008;121:1078-1084.
43. Zaninelli A, Parati G, Cricelli C, Bignamini AA, Modesti PA, Pamparana F, Bilo G, Mancia G, Gensini GF. MARTE Investigators. Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study. J Hypertens 2010;28:910-917.